Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Song S; Han M; Zhang H; Wang Y; Jiang H
  • Source:
    Cellular & molecular immunology [Cell Mol Immunol] 2013 Nov; Vol. 10 (6), pp. 490-6. Date of Electronic Publication: 2013 Aug 19.
  • Publication Type:
    Journal Article; Research Support, Non-U.S. Gov't
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Chinese Society of Immunology;; _b Nature Pub. Group Country of Publication: China NLM ID: 101242872 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-0226 (Electronic) Linking ISSN: 16727681 NLM ISO Abbreviation: Cell Mol Immunol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Beijing, China : Tokyo, Japan : Chinese Society of Immunology; Nature Pub. Group, 2010-
    • Subject Terms:
      Alleles* ; Genetic Testing* ; Histocompatibility Testing*; HLA-A2 Antigen/*genetics ; Polymerase Chain Reaction/*methods ; Sequence Analysis, DNA/*methods; Base Sequence ; China ; Computational Biology ; DNA/genetics ; Exons/genetics ; Genome, Human/genetics ; Haploidy ; Humans ; Reference Standards ; Reproducibility of Results
    • Abstract:
      HLA-A*02 is the most prevalent and polymorphic major histocompatibility complex (MHC) allele family in humans. Functional differences have been revealed among subtypes, demanding further subtyping of HLA-A*02 in basic and clinical settings. However, the fast growing polymorphisms render traditional primer- or probe-based typing methods impractical and result in increasing ambiguities in direct sequence-based typing. In this study, we combined group-specific amplification and mono-allelic sequencing to design and validate a simple scheme for the complete screening and accurate subtyping of all 540 reported HLA-A*02 alleles. This scheme could be performed in routine labs to facilitate studies with an interest in HLA-A*02.
    • References:
      Tissue Antigens. 1995 May;45(5):343-7. (PMID: 7652742)
      Tissue Antigens. 1996 Dec;48(6):673-9. (PMID: 9008310)
      J Immunol. 1995 Nov 15;155(10):4749-56. (PMID: 7594476)
      Tissue Antigens. 1998 Mar;51(3):312-4. (PMID: 9550335)
      Cell Mol Immunol. 2006 Dec;3(6):453-8. (PMID: 17257499)
      Tissue Antigens. 1998 Oct;52(4):389-92. (PMID: 9820604)
      J Exp Med. 1995 Dec 1;182(6):1847-56. (PMID: 7500030)
      BMC Genomics. 2011 Jan 18;12:42. (PMID: 21244689)
      Tissue Antigens. 1995 Apr;45(4):223-31. (PMID: 7638857)
      Immunogenetics. 1995;41(1):50. (PMID: 7806276)
      Nucleic Acids Res. 2013 Jan;41(Database issue):D1222-7. (PMID: 23080122)
      Eur J Immunogenet. 1995 Jun;22(3):283-7. (PMID: 8547235)
      Tissue Antigens. 1995 Jan;45(1):1-11. (PMID: 7725305)
      Tissue Antigens. 2012 Jul;80(1):1-11. (PMID: 22651253)
      Methods Mol Biol. 2012;882:9-25. (PMID: 22665226)
      Tissue Antigens. 2000 Jun;55(6):532-47. (PMID: 10902609)
      Tissue Antigens. 1997 Feb;49(2):129-33. (PMID: 9062968)
      Tissue Antigens. 1995 Mar;45(3):177-87. (PMID: 7761977)
      Eur J Immunol. 2011 Jul;41(7):2097-106. (PMID: 21538979)
      Tissue Antigens. 1996 Mar;47(3):237-44. (PMID: 8740775)
      Methods Mol Med. 2007;134:61-9. (PMID: 17666743)
      Tissue Antigens. 1997 Aug;50(2):178-91. (PMID: 9271828)
      Immunol Res. 2012 Sep;53(1-3):182-90. (PMID: 22434516)
      Methods Mol Biol. 2003;210:191-222. (PMID: 12412456)
    • Accession Number:
      0 (HLA-A*02 antigen)
      0 (HLA-A2 Antigen)
      9007-49-2 (DNA)
    • Publication Date:
      Date Created: 20130820 Date Completed: 20140710 Latest Revision: 20211021
    • Publication Date:
      20231215
    • Accession Number:
      PMC4002391
    • Accession Number:
      10.1038/cmi.2013.33
    • Accession Number:
      23954948